Akron Biotech to Present at BioPartnering Meeting, North America

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) February 16, 2012 -- BOCA RATON, FL – Akron Biotech, a global company with an innovative approach to the field of regenerative medicine, today announced that the company will present at the 10th Annual BioPartnering North America meeting in Vancouver, British Columbia, February 26th- 28th.

BioPartnering North America 2012 (BPN), held at the Vancouver Convention Centre, Canada brings together senior executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size from mature to start-up. With support from global trade associations, conference producers – TVG & Life Science British Columbia, along with hosts – BIOTECanada & BioAlberta, BPN facilitates global business opportunities and strategic partnerships for pharma, investors, and emerging biotech companies.

According to Dr. Claudia Zylberberg, President & CEO of Akron Biotech, "BioPartnering is a great opportunity to showcase Akron’s growth and product line. We increased our reach and presence in the biotechnology market as we grew substantially in 2011, and have a number of great projects in the pipeline for 2012. Our new partnerships bring more value and opportunities to introduce new products and services to the cell therapy market.” At BioPartnering Akron Biotech will be showcasing upcoming products developed in collaboration with some of the world’s leading research institutions.

About Akron Biotech

Akron Biotech a privately held company, has evolved from a reagent and media distributor to a global company with an innovative approach to the field of regenerative medicine. What makes Akron unique is its integrated business model. The company provides its clients in the field of regenerative medicine with cGMP quality recombinant proteins, 3-D scaffolding, cryopreservation media and cell culture supplements. Akron provides its clients with a comprehensive tool-kit to research, test and implement life-saving cellular therapies. Additionally, the company employs its expertise to offer clients process and assay development services to support their regulatory needs. Akron’s services include raw material qualification, process validation and release testing such as bioassays and potency tests for clients including start-up companies, cord blood banks and pharmaceutical companies. The company is headquartered in Boca Raton, Florida.

###